WIVTZNMVNXBLMV-YIIWZEITSA-N
C35H25F9N2O4 — CID 118168620
Data last refreshed: (MolForge compound catalog, from PubChem)
About WIVTZNMVNXBLMV-YIIWZEITSA-N
WIVTZNMVNXBLMV-YIIWZEITSA-N (PubChem CID 118168620) has the molecular formula C35H25F9N2O4 and a molecular weight of 708.58 g/mol. Its IUPAC name is 4-[5-[2-[(3R,3aS,6R)-3-[3,5-bis(trifluoromethyl)phenyl]-3a,4,5,6-tetrahydro-3H-cyclopenta[c][1,2]oxazol-6-yl]-4-(trifluoromethyl)phenyl]-6-methoxy-3-pyridinyl]-3-methylbenzoic acid.
Molecular Properties
| Compound Name | WIVTZNMVNXBLMV-YIIWZEITSA-N |
|---|---|
| PubChem CID | 118168620 |
| Molecular Formula | C35H25F9N2O4 |
| Molecular Weight | 708.58 g/mol |
| Exact Mass | 708.17 |
| IUPAC Name | 4-[5-[2-[(3R,3aS,6R)-3-[3,5-bis(trifluoromethyl)phenyl]-3a,4,5,6-tetrahydro-3H-cyclopenta[c][1,2]oxazol-6-yl]-4-(trifluoromethyl)phenyl]-6-methoxy-3-pyridinyl]-3-methylbenzoic acid |
| SMILES | COc1ncc(-c2ccc(C(=O)O)cc2C)cc1-c1ccc(C(F)(F)F)cc1[C@H]1CC[C@H]2C1=NO[C@H]2c1cc(C(F)(F)F)cc(C(F)(F)F)c1 |
| InChI | InChI=1S/C35H25F9N2O4/c1-16-9-17(32(47)48)3-5-23(16)19-12-28(31(49-2)45-15-19)24-6-4-20(33(36,37)38)14-27(24)25-7-8-26-29(25)46-50-30(26)18-10-21(34(39,40)41)13-22(11-18)35(42,43)44/h3-6,9-15,25-26,30H,7-8H2,1-2H3,(H,47,48)/t25-,26+,30+/m1/s1 |
| InChIKey | WIVTZNMVNXBLMV-YIIWZEITSA-N |
| XLogP | 10.11 |
| TPSA | 81.01 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 50 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 708.58 |
| LogP ≤ 5 | 10.11 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118168620 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.